Does prolactin induce apoptosis? Evidences in a prostate cancer in vitro model

Journal of Endocrinological Investigation

Volumn 33, Issue 5, 2010, Pages 313-317

  Giuffrida, D ^a   Perdichizzi, A ^a   Giuffrida, M C ^a   La Vignera, S ^a   D'Agata, R ^a   Vicari, E ^a   Calogero, A E ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Apoptosis; LNCaP; PC3; Prolactin; Prolactin receptor antagonist; Prostate cancer

Indexed keywords

PROLACTIN; PROPIDIUM IODIDE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; DNA CONTENT; DNA FRAGMENTATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROSCOPY; NICK END LABELING; PROSTATE CANCER;

ADENOCARCINOMA; ANDROGENS; APOPTOSIS; CELL COUNT; CELL LINE, TUMOR; CELL PROLIFERATION; DNA FRAGMENTATION; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HUMANS; IN SITU NICK-END LABELING; LYMPH NODES; MALE; PROLACTIN; PROSTATIC NEOPLASMS; RECEPTORS, PROLACTIN;

EID: 77954198780     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/6720     Document Type: Article

References (23)

1. So AI, Hurtado-Coll A, Gleave ME. Androgens and prostate cancer. World J Urol 2003, 21: 325-37.
2. Reiter E, Hennuy B, Bruyninx M, et al. Effects of pituitary hormones on the prostate. Prostate 1999, 38: 159-65.
3. Ben-Jonathan N, Liby K, McFarland M, Zinger M. Prolactin as an autocrine/paracrine growth factor in human cancer. Trends Endocrinol Metab 2002, 13: 245-50.
4. Costello LC, Franklin RB. Effect of prolactin on the prostate. Prostate 1994, 24: 162-6.
5. Stattin P, Rinaldi S, Stenman UH, et al. Plasma prolactin and prostate cancer risk: A prospective study. Int J Cancer 2001, 92: 463-5. (Pubitemid 32249727)
6. Nevalainen MT, Valve EM, Ingleton PM, Nurmi M, Martikainen PM, Harkonen PL. Prolactin and prolactin receptors are expressed and functioning in human prostate. J Clin Invest 1997, 99: 618-27. (Pubitemid 27097662)
7. Xu X, Kreye E, Kuo CB, Walker AM. A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice. Cancer Res 2001, 61: 6098-104.
8. Ruffion A, Al-Sakkaf KA, Brown BL, Eaton CL, Hamdy FC, Dobson PR. The survival effect of prolactin on PC3 prostate cancer cells. Eur Urol 2003, 43: 301-8.
9. Peirce SK, Chen WY, Chen WY. Quantification of prolactin receptor mRNA in multiple human tissues and cancer cell lines by real time RT-PCR. J Endocrinol 2001, 171: R1-4.
10. Jansen T, Darro F, Petein M, et al. In vitro characterization of prolactin-induced effects on proliferation in the neoplastic LNCaP, DU145, and PC3 models of the human prostate. Cancer 1996, 77: 144-9.
11. Untergasser G, Rumpold H, Hermann M, Dimhofer S, Jilg G, Berger P. Proliferative disorders of the aging human prostate: involvement of protein hormones and their receptors. Exp Gerontol 1999, 34: 275-87.
12. Gadò K, Pallinger E, Kovacs P, et al. Prolactin influences proliferation and apoptosis of a human IgE secreting myeloma cell line, U266. Immunol Lett 2002, 82: 191-6.
13. Yazawa T, Yamamoto T, Abé S. Prolactin induces apoptosis in the penultimate spermatogonial stage of the testes in Japanese redbellied newt (Cynops pyrrhogaster). Endocrinology 2000, 141: 2027-32.
14. Horoszewich JS, Leong S, Kavinski E, et al. LNCaP model of human prostatic carcinoma. Cancer Res 1983, 43: 1809-18.
15. Kaighn MF, Narayan S, Ohnukl Y, Lechner IF, Iones LW. Establishment and characterization of a human prostatic carcinoma cell line (PC3). Invest Urol 1979, 17: 16-23.
16. Lin MF, Garcia-Arenas R, Chao YC, Lai MM, Patel PC, Xia XZ. Regulation of prostatic acid phosphatase expression and secretion by androgen in LNCaP human prostate carcinoma cells. Arch Biochem Biophys 1993, 300: 384-90.
17. Franklin RB, Ekiko DB, Costello LC. Prolactin stimulates transcription of aspartate aminotransferase in prostate cells. Mol Cell Endocrinol 1992, 90: 27-32.
18. Franklin RB, Zou J, Gorski E, Yang YH, Costello LC. Prolactin regulation of mitochondrial aspartate aminotransferase and protein kinase C in human prostate cancer cells. Mol Cell Endocrinol 1997, 127: 19-25.
19. Franklin RB, Costello LC. Prolactin directly stimulates citrate production and mitochondrial aspartate aminotransferase of prostate epithelial cells. Prostate 1990, 17: 13-8.
20. Prins GS. Prolactin influence on cytosol and nuclear androgen receptors in the ventral, dorsal, and lateral lobes of the rat prostate. Endocrinology 1987, 120: 1457-64.
21. Farnsworth WE. Prolactin effect on the permeability of human benign hyperplastic prostate to testosterone. Prostate 1988, 12: 221-9.
22. Reiter E, Bonnet P, Sente B, et al. Growth hormone and prolactin stimulate androgen receptor, insulin-like growth factor-I (IGF-I) and IGF-I receptor levels in the prostate of immature rats. Mol Cell Endocrinol 1992, 88: 77-87.
23. Chen WT, Ramamoorthy P, Chen N, Sticca R, Wagner TE. A human prolactin antagonist, hPRL-G129R, inhibits breast cancer cell proliferation through induction of apoptosis. Clin Cancer Res 1999, 5: 3583-93.